Zymeworks Inc.

ZYME · NasdaqGS

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

–

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders1.3%

Institutions98.8%

Public / Other

Income Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	$105.97M	$76.30M	$76.01M	$412.48M	$26.68M	$38.95M
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	-$92.55M	-$137.11M	-$138.05M	$130.53M	-$215.63M	-$187.47M
Operating income as a percentage of revenue.	-87.3%	-179.7%	-181.6%	31.6%	-808.2%	-481.3%
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	-$81.13M	-$122.69M	-$118.67M	$124.34M	-$211.84M	-$180.55M
Net income divided by the number of shares outstanding — profit attributable to each share.	$-1.08	$-1.62	$-1.72	$1.91	$-4.11	$-3.58
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$-1.08	$-1.62	$-1.72	$1.90	$-4.61	–

Balance Sheet

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$41.16M	$66.10M	$157.56M	$400.91M	$201.87M	$242.04M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$346.53M	$463.09M	$580.88M	$648.73M	$389.13M	–
Everything the company owes — debt, unpaid bills, and other obligations.	$78.03M	$124.32M	$116.07M	$155.77M	$140.04M	–
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$268.50M	$338.77M	$464.81M	$492.96M	$249.09M	–

Cash Flow Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	-$33.01M	-$110.04M	-$118.30M	$144.11M	-$192.45M	-$151.40M
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$1.52M	$1.99M	$2.47M	$8.15M	$12.40M	$4.31M
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	-$34.53M	-$112.03M	-$120.78M	$135.96M	-$204.85M	-$155.71M

	You	Peer avg
P/E	–	6.8
Revenue Growth	-90.6%	-31.8%
ROE	-72.3%	29.7%

Zymeworks Inc.

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Income Statement

Balance Sheet

Cash Flow Statement

Peer Comparison